Effectiveness analysis
| All patients (n=35) | First Episode CDI (n=8) | Recurrence CDI (n=27) | |
|---|---|---|---|
| Clinical Cure (days) | 5 [3–6] | 5 [3–6] | 5 [3–6,8] |
| Recurrence Rate (N(%)) | 12(34,3) | 2(25) | 10(37) |
| Days to Recurrence (days) | 14 [13,3–16,8] | 18,5 [17,2–19,8] | 14 [12,3–14,8] |
| Overall Cure Rate (N(%)) | 23(65,7) | 6(75) | 17(63) |